Estados Unidos · Bolsa y Finanzas · The Motley Fool

Eli Lilly Has Been a Growth Beast, but This Is the Riskiest Part About Its Stock

Publicado por The Motley Fool · Estados Unidos hace 12 h

Eli Lilly ( LLY +0.02%) is the only healthcare stock in the trillion-dollar club, and for good reason. Its business has been booming due to its successful GLP-1 drugs, Mounjaro…

Leer el artículo completo en The Motley Fool Inicie sesión para guardar

MediaNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.fool.com)

Eli Lilly Has Been a Growth Beast, but This Is the Riskiest Part About Its Stock

También te puede interesar

A.I. Officials Stonewall on Questions About Technology’s Risks

Solana Debuts Institutional Settlement Standard With J.P. Morgan Input

Trump says MAGA Inc. PAC will pay for controversial TV ads that government funded

Chinese crime network laundered over $1B for Lazarus: ZachXBT

Exclusive: OpenAI is piloting a ‘mission interview’ for job candidates

Elon Musk is a trillionaire again

Eli Lilly Has Been a Growth Beast, but This Is the Riskiest Part About Its Stock

Compartir

También te puede interesar

A.I. Officials Stonewall on Questions About Technology’s Risks

Solana Debuts Institutional Settlement Standard With J.P. Morgan Input

Trump says MAGA Inc. PAC will pay for controversial TV ads that government funded

Chinese crime network laundered over $1B for Lazarus: ZachXBT

Exclusive: OpenAI is piloting a ‘mission interview’ for job candidates

Elon Musk is a trillionaire again